Tacrolimus Pill

DRUG2 trials

Sponsors

Edward Geissler

Conditions

ImmunosuppressionProphylaxis Against Liver Transplant Rejection

Phase 4

Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients

Active, not recruitingNCT04720326

Edward GeisslerProphylaxis Against Liver Transplant Rejection

Start: 2020-12-23End: 2026-10-31Updated: 2025-04-06

Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs

RecruitingNCT06268769

Edward GeisslerImmunosuppression

Start: 2024-03-09End: 2029-09-30Target: 300Updated: 2024-05-16

Related Papers

EnGraft: a multicentre, open-label, randomised, two-arm, superiority study protocol to assess bioavailability and practicability of Envarsus® versus Advagraf™ in liver transplant recipients.

2023-05-112 citations